The most anticipated drug launches of 2024
Listen now
Description
This week on “The Top Line,” we explore the most anticipated drug launches of 2024. Editor-in-Chief Ayla Ellison engages in a conversation with Fierce Pharma Marketing Senior Editor Ben Adams about the drugs likely to launch this year with the most significant sales potential by 2028.
To learn more about the topics in this episode:
Top 10 most anticipated drug launches of 2024
BMS unwraps $14B deal for Karuna, adding a schizophrenia drug awaiting FDA OK
Bristol Myers Squibb has targeted launch plan for ‘multi-billion-dollar opportunity’ in Karuna schizophrenia drug
Meet Madrigal Pharmaceuticals, which wants to be your liver's No. 1 fan
See omnystudio.com/listener for privacy information.
More Episodes
The Fierce Biotech team published a four-part series this week exploring cell therapy, a modality that has faced clinical challenges, manufacturing constraints and multiple practice-changing events.
In today’s episode, Fierce’s Annalee Armstrong and Gabrielle Masson discuss the series of...
Published 05/31/24
Published 05/31/24
This week’s episode of “The Top Line,” is the final part of a three-part series diving into the latest advancements in cell and gene therapy manufacturing.
In this episode, Fierce Pharma’s Fraiser Kansteiner is joined by Bruce Levine, Ph.D., who is the co-inventor of Kymriah and the Barbara and...
Published 05/24/24
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
